common.study.topics.clinical

Uncontrolled Hypertension Management (TEAM-HTN)

common.study.values.description

Uncontrolled Hypertension Management (TEAM-HTN)

Current guideline directed medical therapies (GDMT) for hypertension (HTN) endorse a trial and error approach based on drug class. This pilot study will evaluate the efficacy of a Clinical Decision Support (CDS) program to assist providers with delivering a more personalized approach using individual renin-aldosterone levels and the mechanism of action of medications included in GDMT recommendations. The overarching goal is to achieve HTN control rates above the 2014 National Health and Nutrition Examination Survey reported rate of 53% in a timely fashion, by individualizing medication management, thereby reducing the patient risk of stroke, heart and renal disease, and other devastating HTN-related outcomes.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Clinical Decision Software - provider portal

As noted in Arms

Clinical Decision Software - patient portal

As noted in Arms

participant.views.study.view.additional

participant.views.study.view.scientific-title

Technology Assisted Management of Uncontrolled Hypertension (TEAM-HTN): a Pilot Study

common.study.values.clinical-trial-id

NCT03281772

participant.views.study.view.id

xe7Zwd